These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8148474)

  • 1. Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers.
    Boisclair MD; Philippou H; Lane DA
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1007-21. PubMed ID: 8148474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC.
    Philippou H; Adami A; Lane DA; MacGregor IR; Tuddenham EG; Lowe GD; Rumley A; Ludlam CA
    Thromb Haemost; 1996 Jul; 76(1):23-8. PubMed ID: 8819246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated coagulation factors in various thrombotic diseases].
    Komiyama Y; Murakami T; Masuda M; Egawa H; Takahashi H
    Rinsho Byori; 1995 Dec; 43(12):1195-200. PubMed ID: 8569028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of intravascular activation of coagulation].
    Zawilska K
    Acta Haematol Pol; 1994; 25(2 Suppl 2):27-33. PubMed ID: 7998471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study.
    Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA
    Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass.
    Boisclair MD; Lane DA; Philippou H; Esnouf MP; Sheikh S; Hunt B; Smith KJ
    Blood; 1993 Dec; 82(11):3350-7. PubMed ID: 8241505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
    Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):713-8, table of contents. PubMed ID: 18292407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory markers of coagulation activation.
    Bauer KA
    Arch Pathol Lab Med; 1993 Jan; 117(1):71-7. PubMed ID: 8418767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A
    Nephrologie; 1992; 13(4):151-7. PubMed ID: 1407255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity.
    Heying R; van Oeveren W; Wilhelm S; Schumacher K; Grabitz RG; Messmer BJ; Seghaye MC
    Crit Care; 2006; 10(6):R165. PubMed ID: 17125503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications.
    Nelson K; Thethi I; Cunanan J; Hoppensteadt D; Bajwa R; Fareed J; Bansal V
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):302-4. PubMed ID: 21159713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.